Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Templé

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Diagnostics (Basel, Switzerland)|July 27, 2022
VEXAS Syndrome: A Novelty in MDS LandscapeMarie Templé, Olivier Kosmider
Rheumatology (Oxford, England)|July 2, 2021
Atypical splice-site mutations causing VEXAS syndromeMarie Templé, Eugénie Duroyon, Carolyne Croizier, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2022
Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric studyLina Khider, Marie Templé, Cécile Bally, et al.
Haematologica|March 30, 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective studyNatacha Johnson, Marie Templé, Chloe Friedrich, et al.
British Journal of Haematology|June 17, 2020
Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patientsJennifer Osman, Jérome Lambert, Marie Templé, et al.
Blood Advances|November 21, 2023
Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemiaJerome Tamburini, Sarah Mouche, Clement Larrue, et al.
Blood Cancer Journal|September 2, 2022
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patientsEstelle Balducci, Sophie Kaltenbach, Patrick Villarese, et al.
Blood|November 21, 2024
Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohortPierre-Edouard Debureaux, Stéphanie Poulain, Stéphanie Harel, et al.
Nature Communications|January 30, 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulationOlivier Kosmider, Céline Possémé, Marie Templé, et al.
Blood|July 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndromePaul Breillat, Francesco Carbone, Emilie Lereclus, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Diagnostics (Basel, Switzerland)|July 27, 2022
VEXAS Syndrome: A Novelty in MDS LandscapeMarie Templé, Olivier Kosmider
Rheumatology (Oxford, England)|July 2, 2021
Atypical splice-site mutations causing VEXAS syndromeMarie Templé, Eugénie Duroyon, Carolyne Croizier, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2022
Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric studyLina Khider, Marie Templé, Cécile Bally, et al.
Haematologica|March 30, 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective studyNatacha Johnson, Marie Templé, Chloe Friedrich, et al.
British Journal of Haematology|June 17, 2020
Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patientsJennifer Osman, Jérome Lambert, Marie Templé, et al.
Blood Advances|November 21, 2023
Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemiaJerome Tamburini, Sarah Mouche, Clement Larrue, et al.
Blood Cancer Journal|September 2, 2022
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patientsEstelle Balducci, Sophie Kaltenbach, Patrick Villarese, et al.
Blood|November 21, 2024
Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohortPierre-Edouard Debureaux, Stéphanie Poulain, Stéphanie Harel, et al.
Nature Communications|January 30, 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulationOlivier Kosmider, Céline Possémé, Marie Templé, et al.
Blood|July 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndromePaul Breillat, Francesco Carbone, Emilie Lereclus, et al.
Pageof 2